News and events

Ensuring Viral Vector Integrity from Day One


NewBiologix’s New White Paper Highlights Novel, Adaptable HEK293 Cell Line for Commercial rAAV Production

Beyond Setbacks: A Vision for Scalable, Smarter Gene Therapy Manufacturing

NewBiologix Presents New Data at ASGCT on the Effective Manufacturing of rAAV-based therapeutics

Interview of Igor Fisch in PharmaBoardroom

NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to Recipharm Advanced Bio for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics

Advancing AAV Manufacturing Quality

Rewards in the Real World: Sitting Down With Igor Fisch

Scaling Platform Delivery of Gene Therapies: An Interview with NewBiologix's CEO Igor Fisch